Nephrology Dialysis Transplantation, Vol 14, Issue 90001 55-57, Copyright © 1999 by Oxford University Press
A Yoshimura, S Uda, K Inui, T Nemoto, Y Sugenoya, S Sharif, N Yokota, S Watanabe and T Ideura
Bcl-2 may account in part for the maintenance of hypercellularity in human
glomerular diseases through preventing cell death and by counteracting bax
which may be expressed to regulate excessive proliferation. This process is
associated with the effect of PDGF B-chain expression. Bax expression may
be important in the cell loss leading to glomerulosclerosis and
TGF-{beta}1 participates in this process by increasing bax expression.
Thus, the balance of bcl-2/bax expression may be critical in the course of
human glomerular diseases.
ORIGINAL ARTICLES
Expression of bcl-2 and bax in glomerular disease
Department of Medicine, Division of Nephrology, Showa University Fujigaoka Hospital, 1-30 Fujigaoka, Aoba-ku, Yokohama 227, Japan; Corresponding author
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. Erkan, P. Devarajan, and G. J. Schwartz Mitochondria Are the Major Targets in Albumin-Induced Apoptosis in Proximal Tubule Cells J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1199 - 1208. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-Q. Qiu, R. Sinniah, and S. I-Hong Hsu Downregulation of Bcl-2 by Podocytes Is Associated with Progressive Glomerular Injury and Clinical Indices of Poor Renal Prognosis in Human IgA Nephropathy J. Am. Soc. Nephrol., January 1, 2004; 15(1): 79 - 90. [Abstract] [Full Text] [PDF] |
||||
